Summary
CRH Public Limited Company (CRH) has filed a Form 6-K report with the SEC on March 14, 2008, to disclose a change in director details. This filing is a notification in accordance with paragraph 6.6.8(2) of the Listing Rules. Investors should note that this is a routine disclosure related to corporate governance and director appointments rather than a financial performance announcement. The key information conveyed is the appointment of Prof. U-H. Felcht to the Supervisory Board of Sud-Chemie Aktiengesellschaft, effective February 4, 2008. This information is provided to ensure compliance with regulatory requirements regarding director declarations and board memberships.
Key Highlights
- 1CRH filed a Form 6-K report on March 14, 2008.
- 2The filing is a 'Director Declaration' to notify of a change in director details.
- 3Prof. U-H. Felcht was appointed to the Supervisory Board of Sud-Chemie Aktiengesellschaft on February 4, 2008.
- 4This disclosure complies with paragraph 6.6.8(2) of the Listing Rules.
- 5The report is filed by a foreign issuer (CRH Public Limited Company, Ireland).
- 6The filing indicates CRH files annual reports under Form 20-F.
- 7M. Lee, Finance Director, signed the report on behalf of CRH.
Frequently Asked Questions
The main purpose of this filing is to notify the SEC and investors about a change in director details, specifically the appointment of Prof. U-H. Felcht to the Supervisory Board of Sud-Chemie Aktiengesellschaft. This is a regulatory compliance filing.
No, this filing does not report on CRH's financial performance or significant business developments. It is a routine disclosure regarding a director's appointment to an external board, made to comply with listing rules.
Prof. U-H. Felcht is an individual appointed to the Supervisory Board of Sud-Chemie Aktiengesellschaft. Sud-Chemie Aktiengesellschaft is a company (likely in Germany given the name) on whose board Prof. Felcht now serves. CRH is disclosing this because it is a director of CRH or a related entity.
The 'Listing Rules' likely refer to the rules set by the stock exchange where CRH's securities are listed, which require disclosure of changes in directorships or board memberships of significant entities associated with the company's directors.